REDWOOD CITY, Calif., June 17 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life science researchers, today released IPA 6.3, the newest version of its pathway analysis and life sciences knowledge software. IPA now supports Affymetrix GeneChip(R) Exon Arrays and several new animal and plant species.
Currently, IPA supports a variety of different research platforms including gene expression, proteomics, SNPs, genotyping, and RNAi. Now with the support of Affymetrix GeneChip Exon Arrays, researchers using this system can use IPA for further analysis and interpretation of the gene expression data. IPA will provide a rapid assessment of the signaling and metabolic pathways, molecular networks, and biological processes most significantly perturbed in the dataset being examined.
"We're excited that Ingenuity's IPA now supports Affymetrix Whole Transcript Exon and Gene Arrays," stated Rob Clum, Market Development Manager, Informatics, Affymetrix. "Our array technology is designed to provide the most detailed view of gene expression, and IPA helps researchers go a step further to better understand the underlying biology involved in their experimental system."
"IPA 6.3 provides significant new customer benefits by supporting additional research platforms," commented Brigitte Ganter, Ph.D., Director of Product Management, Ingenuity Systems. "Researchers using Affymetrix Exon Arrays can now leverage IPA to identify the molecular networks, cellular and disease phenotypes, and pathways most significantly associated with their datasets for a deeper understanding of the complex systems they are studying. IPA now also supports key animal and plant species, which are essential for our customers whose primary research involves model organisms like Drosophila, Zebrafish, Arabidopsis, or others."
About Ingenuity Pathways Analysis
Ingenuity Pathways Analysis is an all-in-one software application that enables researchers to model, analyze, and understand the complex biological and chemical systems at the core of life science research. IPA's search capabilities provide users with access to the highest quality detail-rich knowledge available on genes, drugs, chemicals, protein families, cellular and disease processes, and signaling and metabolic pathways. IPA supports analysis of data from all experimental platforms, and is used at all stages of the drug discovery and development process, including target identification and validation, biomarker discovery, molecular toxicology, metabolomics, and pharmacogenomics. IPA has been broadly adopted and cited in hundreds of peer-reviewed journals.
About Ingenuity Systems(R)
Ingenuity Systems is a leading provider of information solutions for the exploration, interpretation, and analysis of life science information. All of Ingenuity's products and services have one common goal -- to help life science researchers generate maximum value from all types of biological and chemical knowledge. Ingenuity offers a broad and flexible range of solutions that can be tailored to needs of various clients, including academic and therapeutic area researchers, computational biologists and informatics departments, and suppliers in the life sciences industry. All of the products leverage Ingenuity's knowledge base, the largest data base of its kind, which houses the biological and chemical relationships extracted from scientific literature. The information is uniquely structured so scientists can ask complex biological questions to gain rapid insight into their experimental data or create relevant biological models to move forward in their research. Today, Ingenuity's solutions are used by thousands of researchers at hundreds of leading pharmaceutical, biotechnology, and academic research institutions worldwide. Ingenuity was founded in 1998 and is headquartered in Redwood City, California with offices in Germany, Switzerland, France, the United Kingdom, Australia, and Japan. http://www.ingenuity.com.
|SOURCE Ingenuity Systems|
Copyright©2008 PR Newswire.
All rights reserved